Cases 1 - 10 of 124
Novo Nordisk Inc. et al v. Sun Pharmaceutical Industries Ltd. et al
as 1:2023cv01459
Plaintiff:
Novo Nordisk Inc. and Novo Nordisk A/S
Defendant:
Sun Pharmaceutical Industries Ltd. and Sun Pharmaceutical Industries, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
AbbVie Inc. v. Hetero USA, Inc. et al
as 1:2023cv01332
Plaintiff:
AbbVie Inc.
Defendant:
Hetero USA, Inc., Hetero Labs Limited, Hetero Labs Limited Unit-V and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
DUSA Pharmaceuticals, Inc. et al v. Biofrontera Inc.
as 3:2023cv20601
Plaintiff:
DUSA PHARMACEUTICALS, INC., SUN PHARMACEUTICAL INDUSTRIES INC and SUN PHARMACEUTICAL INDUSTRIES LTD
Defendant:
Biofrontera Inc., BIOFRONTERA BIOSCIENCE GMBH, BIOFRONTERA PHARMA GMBH and others
Cause Of Action: 15 U.S.C. § 1125 Trademark Infringement (Lanham Act)
ASTELLAS PHARMA INC. v. SUN PHARMACEUTICAL INDUSTRIES, INC. et al
as 2:2022cv07357
Plaintiff:
ASTELLAS PHARMA INC., ASTELLAS US LLC, ASTELLAS PHARMA US, INC. and others
Defendant:
SUN PHARMACEUTICAL INDUSTRIES, INC. and SUN PHARMACEUTICAL INDUSTRIES LTD.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
ASTELLAS PHARMA INC. v. SUN PHARMACEUTICAL INDUSTRIES, INC. et al
as 3:2022cv07357
Plaintiff:
ASTELLAS PHARMA INC.
Defendant:
SUN PHARMACEUTICAL INDUSTRIES, INC. and SUN PHARMACEUTICAL INDUSTRIES LTD.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Pfizer Inc. et al v. Sun Pharmaceutical Industries Ltd. et al
as 1:2022cv01501
Plaintiff:
Pfizer Inc., C.P. Pharmaceuticals International C.V., PF Prism C.V. and others
Defendant:
Sun Pharmaceutical Industries Ltd. and Sun Pharmaceutical Industries, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
ADELMAN et al v. APOTEX CORPORATION et al
as 2:2022cv03179
Plaintiff:
David Adelman, Glen Horay, Steve Monillas and others
Defendant:
APOTEX CORPORATION, PATHEON MANUFACTURING SERVICES LLC, WATSON LABORATORIES, INC. and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Notice of Removal
In Re: Ozempic (Semaglutide) Patent Litigation
as 1:2022md03038
Not Classified By Court:
Zydus Lifesciences Limited, Ozempic (Semaglutide) Patent Litigation, Novo Nordisk Inc. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Takeda Pharmaceuticals U.S.A., Inc. et al v. Sun Pharmaceutical Industries Ltd. et al
as 1:2022cv00911
Plaintiff:
Takeda Pharmaceuticals U.S.A., Inc. and Takeda Pharmaceutical Company Ltd.
Defendant:
Sun Pharmaceutical Industries Ltd. and Sun Pharmaceutical Industries, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novo Nordisk Inc. et al v. Sun Pharmaceutical Industries, Inc., et al
as 1:2022cv00897
Plaintiff:
Novo Nordisk Inc. and Novo Nordisk A/S
Defendant:
Sun Pharmaceutical Industries Ltd. and Sun Pharmaceutical Industries, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
